Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valter Gattei

Showing results (121-130 of 190) with videos related to

Pageof 19
Sort By:
Hematological Oncology|November 16, 2021
Elastin MIcrofibriL INterfacer1 (EMILIN-1) is an alternative prosurvival VLA-4 ligand in chronic lymphocytic leukemiaErika Tissino, Eliana Pivetta, Alessandra Capuano, et al.
Annals of Hematology|June 14, 2014
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatmentMichele Dal Bo, Maria Ilaria Del Principe, Federico Pozzo, et al.
British Journal of Haematology|May 22, 2008
Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndromeDavide Rossi, Michaela Cerri, Daniela Capello, et al.
International Journal of Laboratory Hematology|September 10, 2024
A new digital droplet PCR method for looking at epigenetics in diffuse large B-cell lymphomas: The role of BMI1, EZH2, and USP22 genesAlessio Lusci Gemignani, Robel Papotti, Riccardo Bomben, et al.
Plos One|October 8, 2013
New potential therapeutic approach for the treatment of B-Cell malignancies using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticlesNelly Mezzaroba, Sonia Zorzet, Erika Secco, et al.
British Journal of Haematology|July 13, 2022
Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndromeChiara Favini, Donatella Talotta, Mohammad Almasri, et al.
Haematologica|October 14, 2011
CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling studyGiovanni Del Poeta, Maria Ilaria Del Principe, Antonella Zucchetto, et al.
Blood Advances|June 10, 2025
Expression of HERV-K and embryonic genes in chronic lymphocytic leukemia and their association with therapy regimensClaudia Matteucci, Vita Petrone, Alessandro Giovinazzo, et al.
Journal of Hematology & Oncology|November 29, 2013
Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical applicationFederico Pozzo, Michele Dal Bo, Nadia Peragine, et al.
British Journal of Haematology|December 3, 2010
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndromeSilvia Rasi, Valeria Spina, Alessio Bruscaggin, et al.
Pageof 19

Showing results (121-130 of 190) with videos related to

Sort By:
Pageof 19
Hematological Oncology|November 16, 2021
Elastin MIcrofibriL INterfacer1 (EMILIN-1) is an alternative prosurvival VLA-4 ligand in chronic lymphocytic leukemiaErika Tissino, Eliana Pivetta, Alessandra Capuano, et al.
Annals of Hematology|June 14, 2014
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatmentMichele Dal Bo, Maria Ilaria Del Principe, Federico Pozzo, et al.
British Journal of Haematology|May 22, 2008
Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndromeDavide Rossi, Michaela Cerri, Daniela Capello, et al.
International Journal of Laboratory Hematology|September 10, 2024
A new digital droplet PCR method for looking at epigenetics in diffuse large B-cell lymphomas: The role of BMI1, EZH2, and USP22 genesAlessio Lusci Gemignani, Robel Papotti, Riccardo Bomben, et al.
Plos One|October 8, 2013
New potential therapeutic approach for the treatment of B-Cell malignancies using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticlesNelly Mezzaroba, Sonia Zorzet, Erika Secco, et al.
British Journal of Haematology|July 13, 2022
Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndromeChiara Favini, Donatella Talotta, Mohammad Almasri, et al.
Haematologica|October 14, 2011
CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling studyGiovanni Del Poeta, Maria Ilaria Del Principe, Antonella Zucchetto, et al.
Blood Advances|June 10, 2025
Expression of HERV-K and embryonic genes in chronic lymphocytic leukemia and their association with therapy regimensClaudia Matteucci, Vita Petrone, Alessandro Giovinazzo, et al.
Journal of Hematology & Oncology|November 29, 2013
Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical applicationFederico Pozzo, Michele Dal Bo, Nadia Peragine, et al.
British Journal of Haematology|December 3, 2010
A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndromeSilvia Rasi, Valeria Spina, Alessio Bruscaggin, et al.
Pageof 19